insights_auto
为什么 BT3 下跌了 5.17%?
深入探索chevron_right
BT3:FRA
Lineage Cell Therapeutics Inc
€0.79
arrow_downward
-5.17%(-0.043) 1 天
10月14日, GMT+2 08:01:17 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 BT3 生成关键数据洞见…
开盘价
€0.79
最高价
€0.79
最低价
€0.79
市值
2.31亿
平均成交量
37.00
成交量
0.00
52 周最高价
€1.69
52 周最低价
€0.78
员工人数
75
开盘价
€0.79
最高价
€0.79
最低价
€0.79
市值
2.31亿
平均成交量
37.00
成交量
0.00
52 周最高价
€1.69
52 周最低价
€0.78
员工人数
75
新闻报道
来自网络来源和新闻合作伙伴
资料
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Lineage Cell Therapeutics Inc简介